About OptMed
OptMed, Inc. develops and commercializes biocompatible polymer and genitourinary therapeutic platforms. Its biocompatible polymers platform serves for biosurgical adhesive and sealant, and industrial adhesive applications. The company’s and genitourinary therapeutics platform serves for the treatment of lower urinary tract conditions, including overactive bladder and kidney stones. Its products include Devakor, a topical skin adhesive for surgical sutures. OptMed, Inc. was incorporated in 2007 and is based in Woodmere, New York.
|
|
|
11-50 employees
View all OptMed employees
|
|
Biotechnology Research
|
|
(212) 867-4141
|
|
New York, New York
|
|
2007
|
OptMed Alternatives
Frequently Asked Questions about OptMed
Alain Klapholz is the CEO of OptMed. To contact Alain Klapholz email at [email protected].
The decision makers in OptMed are Alain Klapholz, Alain Klapholz, Ervin Braun, etc. Click to Find OptMed decision makers emails.
OptMed Staff Directory
Search OptMed Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
